La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Contribution of Insula in Parkinson’s Disease: A Quantitative Meta-Analysis Study

Identifieur interne : 000878 ( Pmc/Corpus ); précédent : 000877; suivant : 000879

Contribution of Insula in Parkinson’s Disease: A Quantitative Meta-Analysis Study

Auteurs : Marion Criaud ; Leigh Christopher ; Philippe Boulinguez ; Benedicte Ballanger ; Anthony E. Lang ; Sang S. Cho ; Sylvain Houle ; Antonio P. Strafella

Source :

RBID : PMC:4874784

Abstract

The insula region is known to be an integrating hub interacting with multiple brain networks involved in cognitive, affective, sensory, and autonomic processes. There is growing evidence suggesting that this region may have an important role in Parkinson’s disease (PD). Thus, to investigate the functional organization of the insular cortex and its potential role in parkinsonian features, we used a coordinate-based quantitative meta-analysis approach, the activation likelihood estimation. A total of 132 insular foci were selected from 96 published experiments comprising the five functional categories: cognition, affective/behavioral symptoms, bodily awareness/autonomic function, sensorimotor function, and nonspecific resting functional changes associated with the disease. We found a significant convergence of activation maxima related to PD in different insular regions including anterior and posterior regions bilaterally. This study provides evidence of an important functional distribution of different domains within the insular cortex in PD, particularly in relation to nonmotor aspects, with an influence of medication effect.


Url:
DOI: 10.1002/hbm.23109
PubMed: 26800238
PubMed Central: 4874784

Links to Exploration step

PMC:4874784

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Contribution of Insula in Parkinson’s Disease: A Quantitative Meta-Analysis Study</title>
<author>
<name sortKey="Criaud, Marion" sort="Criaud, Marion" uniqKey="Criaud M" first="Marion" last="Criaud">Marion Criaud</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A3">Division of Brain, Imaging and Behaviour – Systems Neuroscience, Krembil Research Institute, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A4">Université Lyon 1, Villeurbanne, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A5">Centre De Neuroscience Cognitive, CNRS, UMR5229, Bron, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A6">Université De Lyon, Lyon, F-69622, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Christopher, Leigh" sort="Christopher, Leigh" uniqKey="Christopher L" first="Leigh" last="Christopher">Leigh Christopher</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A3">Division of Brain, Imaging and Behaviour – Systems Neuroscience, Krembil Research Institute, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Boulinguez, Philippe" sort="Boulinguez, Philippe" uniqKey="Boulinguez P" first="Philippe" last="Boulinguez">Philippe Boulinguez</name>
<affiliation>
<nlm:aff id="A4">Université Lyon 1, Villeurbanne, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A5">Centre De Neuroscience Cognitive, CNRS, UMR5229, Bron, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A6">Université De Lyon, Lyon, F-69622, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ballanger, Benedicte" sort="Ballanger, Benedicte" uniqKey="Ballanger B" first="Benedicte" last="Ballanger">Benedicte Ballanger</name>
<affiliation>
<nlm:aff id="A4">Université Lyon 1, Villeurbanne, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A5">Centre De Neuroscience Cognitive, CNRS, UMR5229, Bron, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A6">Université De Lyon, Lyon, F-69622, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cho, Sang S" sort="Cho, Sang S" uniqKey="Cho S" first="Sang S." last="Cho">Sang S. Cho</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A3">Division of Brain, Imaging and Behaviour – Systems Neuroscience, Krembil Research Institute, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P." last="Strafella">Antonio P. Strafella</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A3">Division of Brain, Imaging and Behaviour – Systems Neuroscience, Krembil Research Institute, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">26800238</idno>
<idno type="pmc">4874784</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874784</idno>
<idno type="RBID">PMC:4874784</idno>
<idno type="doi">10.1002/hbm.23109</idno>
<date when="2016">2016</date>
<idno type="wicri:Area/Pmc/Corpus">000878</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000878</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Contribution of Insula in Parkinson’s Disease: A Quantitative Meta-Analysis Study</title>
<author>
<name sortKey="Criaud, Marion" sort="Criaud, Marion" uniqKey="Criaud M" first="Marion" last="Criaud">Marion Criaud</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A3">Division of Brain, Imaging and Behaviour – Systems Neuroscience, Krembil Research Institute, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A4">Université Lyon 1, Villeurbanne, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A5">Centre De Neuroscience Cognitive, CNRS, UMR5229, Bron, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A6">Université De Lyon, Lyon, F-69622, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Christopher, Leigh" sort="Christopher, Leigh" uniqKey="Christopher L" first="Leigh" last="Christopher">Leigh Christopher</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A3">Division of Brain, Imaging and Behaviour – Systems Neuroscience, Krembil Research Institute, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Boulinguez, Philippe" sort="Boulinguez, Philippe" uniqKey="Boulinguez P" first="Philippe" last="Boulinguez">Philippe Boulinguez</name>
<affiliation>
<nlm:aff id="A4">Université Lyon 1, Villeurbanne, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A5">Centre De Neuroscience Cognitive, CNRS, UMR5229, Bron, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A6">Université De Lyon, Lyon, F-69622, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ballanger, Benedicte" sort="Ballanger, Benedicte" uniqKey="Ballanger B" first="Benedicte" last="Ballanger">Benedicte Ballanger</name>
<affiliation>
<nlm:aff id="A4">Université Lyon 1, Villeurbanne, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A5">Centre De Neuroscience Cognitive, CNRS, UMR5229, Bron, France</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A6">Université De Lyon, Lyon, F-69622, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cho, Sang S" sort="Cho, Sang S" uniqKey="Cho S" first="Sang S." last="Cho">Sang S. Cho</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A3">Division of Brain, Imaging and Behaviour – Systems Neuroscience, Krembil Research Institute, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P." last="Strafella">Antonio P. Strafella</name>
<affiliation>
<nlm:aff id="A1">Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A2">Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="A3">Division of Brain, Imaging and Behaviour – Systems Neuroscience, Krembil Research Institute, UHN, University of Toronto, Ontario, Canada</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Human brain mapping</title>
<idno type="ISSN">1065-9471</idno>
<idno type="eISSN">1097-0193</idno>
<imprint>
<date when="2016">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">The insula region is known to be an integrating hub interacting with multiple brain networks involved in cognitive, affective, sensory, and autonomic processes. There is growing evidence suggesting that this region may have an important role in Parkinson’s disease (PD). Thus, to investigate the functional organization of the insular cortex and its potential role in parkinsonian features, we used a coordinate-based quantitative meta-analysis approach, the activation likelihood estimation. A total of 132 insular foci were selected from 96 published experiments comprising the five functional categories: cognition, affective/behavioral symptoms, bodily awareness/autonomic function, sensorimotor function, and nonspecific resting functional changes associated with the disease. We found a significant convergence of activation maxima related to PD in different insular regions including anterior and posterior regions bilaterally. This study provides evidence of an important functional distribution of different domains within the insular cortex in PD, particularly in relation to nonmotor aspects, with an influence of medication effect.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9419065</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21028</journal-id>
<journal-id journal-id-type="nlm-ta">Hum Brain Mapp</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum Brain Mapp</journal-id>
<journal-title-group>
<journal-title>Human brain mapping</journal-title>
</journal-title-group>
<issn pub-type="ppub">1065-9471</issn>
<issn pub-type="epub">1097-0193</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26800238</article-id>
<article-id pub-id-type="pmc">4874784</article-id>
<article-id pub-id-type="doi">10.1002/hbm.23109</article-id>
<article-id pub-id-type="manuscript">CAMS5626</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Contribution of Insula in Parkinson’s Disease: A Quantitative Meta-Analysis Study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Criaud</surname>
<given-names>Marion</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Christopher</surname>
<given-names>Leigh</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boulinguez</surname>
<given-names>Philippe</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ballanger</surname>
<given-names>Benedicte</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lang</surname>
<given-names>Anthony E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Sang S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Houle</surname>
<given-names>Sylvain</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Strafella</surname>
<given-names>Antonio P.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref rid="FN1" ref-type="author-notes">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>
Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada</aff>
<aff id="A2">
<label>2</label>
Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada</aff>
<aff id="A3">
<label>3</label>
Division of Brain, Imaging and Behaviour – Systems Neuroscience, Krembil Research Institute, UHN, University of Toronto, Ontario, Canada</aff>
<aff id="A4">
<label>4</label>
Université Lyon 1, Villeurbanne, France</aff>
<aff id="A5">
<label>5</label>
Centre De Neuroscience Cognitive, CNRS, UMR5229, Bron, France</aff>
<aff id="A6">
<label>6</label>
Université De Lyon, Lyon, F-69622, France</aff>
<author-notes>
<corresp id="FN1">
<label>*</label>
Correspondence to: Antonio P. Strafella, MD, PhD, FRCPC; Toronto Western Hospital and Institute, UHN & Research Imaging Centre, CAMH, University of Toronto, Toronto, Ontario, Canada.
<email>antonio.strafella@uhn.ca</email>
and
<email>antonio.strafella@camhpet.ca</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2017</year>
</pub-date>
<volume>37</volume>
<issue>4</issue>
<fpage>1375</fpage>
<lpage>1392</lpage>
<pmc-comment>elocation-id from pubmed: 10.1002/hbm.23109</pmc-comment>
<abstract>
<p id="P1">The insula region is known to be an integrating hub interacting with multiple brain networks involved in cognitive, affective, sensory, and autonomic processes. There is growing evidence suggesting that this region may have an important role in Parkinson’s disease (PD). Thus, to investigate the functional organization of the insular cortex and its potential role in parkinsonian features, we used a coordinate-based quantitative meta-analysis approach, the activation likelihood estimation. A total of 132 insular foci were selected from 96 published experiments comprising the five functional categories: cognition, affective/behavioral symptoms, bodily awareness/autonomic function, sensorimotor function, and nonspecific resting functional changes associated with the disease. We found a significant convergence of activation maxima related to PD in different insular regions including anterior and posterior regions bilaterally. This study provides evidence of an important functional distribution of different domains within the insular cortex in PD, particularly in relation to nonmotor aspects, with an influence of medication effect.</p>
</abstract>
<kwd-group>
<kwd>Parkinson’s disease</kwd>
<kwd>insula</kwd>
<kwd>nonmotor symptoms</kwd>
<kwd>dopamine</kwd>
<kwd>cognition</kwd>
<kwd>behavior</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000878 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000878 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:4874784
   |texte=   Contribution of Insula in Parkinson’s Disease: A Quantitative Meta-Analysis Study
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:26800238" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022